Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interfant-99 infant ALL trial
NL-OMON21662Active, not recruiting
- Sponsor
- Interfant Collaborative Group
- Start
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of cytarabine in acute lymphoblastic leukemia (ALL), sponsored by Interfant Collaborative Group. Primary endpoint: Event-free survival. Started Jan 1999; status: active, not recruiting.
02
Drugs
cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON21662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21662.